Align Technology, Inc.
131.91-1.23 (-0.92%)
Oct 29, 4:00:02 PM EDT · NasdaqGS · ALGN · USD
Key Stats
Market Cap
9.56BP/E (TTM)
22.24Basic EPS (TTM)
5.93Dividend Yield
0%Recent Filings
8-K
8-K
HR exec termination announced
Align Technology terminated Executive Vice President of Global Human Resources Stuart Hockridge on September 12, 2025, effective May 2026, without cause under his 2016 employment agreement. Severance and benefits will align with proxy disclosures for non-change-of-control terminations. This leadership shift signals a strategic HR pivot. No interim arrangements disclosed.
10-Q
Q2 FY2025 results
Align Technology's Q2 FY2025 results showed net revenues dipping 1.6% y/y to $1.01B, with Clear Aligner down 3.3% y/y to $805M amid softer ASPs from product mix shifts, yet Systems and Services rose 5.6% y/y to $208M on scanner wand strength. Gross margin held at 69.9%, while operating income climbed 10.9% y/y to $163M (derived), lifting diluted EPS 34.4% y/y to $1.72 on 72.6M shares—EPS reconciles cleanly. Cash from operations hit $181M YTD, yielding $134M FCF after $47M capex, with $901M cash and full $300M revolver availability, no debt. The Cubicure acquisition closed Jan 2024 for $85.8M cash, adding $47.6M goodwill and $47M intangibles over 13 years to bolster digital printing. Antitrust suits linger, with a $31.8M Section 1 settlement pending final approval.
8-K
Align launches $200M buyback
Align Technology announced plans to repurchase $200 million of its common stock via open market transactions under its $1.0 billion program approved in April 2025. This move signals management's confidence in the long-term strategy amid macroeconomic uncertainty, funded by cash on hand with completion targeted by January 2026. Repurchases enhance shareholder value. Yet risks like market volatility could alter timing.
8-K
Mixed Q2 results, restructuring ahead
Align Technology posted Q2 2025 revenues of $1,012.4 million, down 1.6% year-over-year despite a 3.4% sequential rise, with Clear Aligner sales slipping 3.3% to $804.6 million on flat case volumes of 644.4 thousand, while Imaging Systems jumped 5.6% to $207.8 million. Operating income hit $163.0 million at a 16.1% margin, but the company flagged uneven case conversions from tariff uncertainty and financing hurdles. Restructuring kicks in H2 2025, eyeing $150–170 million charges for workforce cuts and manufacturing tweaks to boost FY25 non-GAAP margins above 22.5%. Economic hesitancy lingers.
IPO
Website
Employees
Sector
Industry
ALC
Alcon Inc.
73.60-1.22
ALHC
Alignment Healthcare, Inc.
18.21+0.17
DROR
Dror Ortho-Design Inc.
0.03-0.00
GEHC
GE HealthCare Technologies Inc.
77.38-2.02
INGN
Inogen, Inc
8.41-0.12
NVST
Envista Holdings Corporation
19.98-0.08
RTGN
RETINALGENIX TECHNOLOGIES INC
3.75+0.00
VVOS
Vivos Therapeutics, Inc.
2.67+0.07
XRAY
DENTSPLY SIRONA Inc.
12.86-0.21
ZIMV
ZimVie Inc.
18.99+0.00